Intussusception Market Size Forecasted To Achieve $5.52 Billion By 2029 With Steady Growth

The Intussusception Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Intussusception Market Size and Projected Growth Rate?
In recent years, the intussusception market has exhibited robust growth. Its size is projected to increase from $4.45 billion in 2024 to $4.69 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.3%. Factors contributing to the growth observed in the historic period include enhancements in diagnostic technologies, greater awareness and education, expansion of the global healthcare infrastructure, increased investments in research and development, and collaborations among healthcare entities.

Expectations are that the intussusception market will see consistent growth in the ensuing years. The projection is that it will expand to $5.52 billion by 2029, with a compound annual growth rate (CAGR) of 4.1%. This escalation during the forecast period can be credited to continuous medical training endeavours, child vaccination initiatives, worldwide contributions towards child healthcare, emphasis on post-surgical care, increased need for research in pediatric gastroenterology, and accessible remote healthcare and telemedicine. Significant trends within this forecast period encompass progress in diagnostic imaging, less intrusive treatment methods, developments of interventions targeted for children, investigations about the cause and factors of risk, worldwide epidemiological studies, the execution of vaccination programs, and the use of telemedicine for diagnosis and consultation.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13466

What Are the Major Segments in the Intussusception Market?
The intussusception market covered in this report is segmented -

1) By Type: Idiopathic Intussusception, Secondary Intussusception
2) By Treatment: Enema Reduction, Surgery, Other Treatment
3) By Diagnosis: Barium Enema, Ultrasound, X-Ray, Computerized Tomography (CT)
4) By End-User: Hospitals, Clinics, Other End-User

Subsegments:
1) By Idiopathic Intussusception: Childhood Idiopathic Intussusception, Adult Idiopathic Intussusception
2) By Secondary Intussusception: Neoplastic Intussusception, Infectious Intussusception, Inflammatory Intussusception, Post-Surgical Intussusception

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13466&type=smp

What Are The Driving Intussusception Market Evolution?
The intussusception market is projected to grow due to the escalating occurrence of intestinal disorders. Intestinal disorders disrupt the regular operations of the intestines, vital organs in the digestive system that absorb nutrients and expel waste. Conditions such as inflammatory bowel disease and gastrointestinal cancers, classified under intestinal disorders, can lead to early detection and improved therapeutic solutions. This enhances the support for patients suffering from intussusception, ultimately improving their quality of life. In January 2023, for instance, the American Cancer Society (ACS) reported a 3.18% increase in gastrointestinal cancers to 348,840, compared to 338,090 in 2021, in the US. Therefore, the growth of the intussusception market is fueled by the mounting prevalence of intestinal disorders. Growth of Intussusception Market Bolstered by Rising Healthcare Expenditure

Which Firms Dominate The Intussusception Market Segments?
Major companies operating in the intussusception market report are Pfizer Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Bristol-Myers Squibb Company, Abbott Laboratories, Sanofi S.A., GlaxoSmithKline PLC, Stryker Corporation, Boston Scientific Corporation, Biogen Inc., Olympus Corporation, GE HealthCare Technologies Inc., Steris PLC, Cook Medical LLC, Shimadzu Corporation, Carestream Health, CONMED Corporation, Janssen Pharmaceuticals Inc., EndoChoice Holdings Inc., Fujifilm Healthcare Solutions, Basilea Pharmaceutica Ltd., Richard Wolf GmbH, Karl Storz SE And Co. KG, Eizoflex Co. Ltd., Arena Pharmaceuticals Inc.

What Trends Are Driving Growth in The Intussusception Market?
Key players in the intestinal pseudo-obstruction treatment market are pioneering innovative drug treatments such as NHE3 inhibitor treatment therapy, in an effort to offer trustworthy solutions to their customers. The NHE3 inhibitor treatment therapy is a drug that acts by impeding the Sodium-Proton-Exchanger subtype 3 (NHE3) in the intestines. In a notable development in April 2022, Ardelyx Inc., a respected biopharmaceutical firm from the United States, launched IBSRELA, an NHE3 inhibitor therapy for adults suffering from irritable bowel syndrome with constipation (IBS-C). This could potentially enhance gastrointestinal mobility. IBSRELA treatment therapy acts by obstructing the operation of the Sodium-Hydrogen Exchanger 3 (NHE3) protein. The sanction for IBSRELA was grounded on two Phase 3 studies involving over 1,200 IBS-C patients. It exhibited significant improvements in abdominal discomfort and bowel movement, achieving the principal objective. The enhancements were noticed as soon as Week 1 and were maintained for 26 weeks in the extended trial.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/intussusception-global-market-report

Which Is The Largest Region In The Intussusception Market?
North America was the largest region in the intussusception market in 2024. The regions covered in the intussusception market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Intussusception Market?
2. What is the CAGR expected in the Intussusception Market?
3. What Are the Key Innovations Transforming the Intussusception Industry?
4. Which Region Is Leading the Intussusception Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.